Financials SciBase Holding AB

Stocks

End-of-day quote Nasdaq Stockholm Other stock markets 2026-07-24			5-day change	1st Jan Change
33.50 ^SEK	-2.33%		-4.83%	-2.90%

07-01	SciBase Holding AB Submits FDA 510(k) to Expand Nevisense Indication for Non-Melanoma Skin Cancer Assessment	CI
06-10	SciBase Holding AB and Castle Biosciences Enroll First Patient in New Study Assessing Early Prediction of Flares in Atopic Dermatitis	CI

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Net sales ¹	-	17.89	23.24	29.7	40.46	65.9	104.2	152.3
Change	-	-	29.93%	27.79%	36.21%	62.87%	58.12%	46.16%
EBITDA ¹	-	-42.77	-50.55	-63.94	-82.72	-66.2	-46.3	-14.5
Change	-	-	-18.2%	-26.49%	-29.38%	19.97%	30.06%	68.68%
EBIT ¹	-	-46.42	-53.94	-67.17	-86.41	-66.2	-51.5	-19.3
Change	-	-	-16.2%	-24.54%	-28.64%	23.39%	22.21%	62.52%
Interest Paid	-	-	-	6.049	-0.649	-	-	-
Earnings before Tax (EBT) ¹	-	-43.17	-55.58	-61.12	-87.06	-66.3	-51.5	-19.3
Change	-	-	-28.75%	-9.97%	-42.43%	23.85%	22.32%	62.52%
Net income ¹	-41.78	-43.17	-55.58	-61.12	-87.06	-66.3	-51.5	-19.3
Change	-	-3.34%	-28.75%	-9.97%	-42.43%	23.85%	22.32%	62.52%
Announcement Date	4/22/22	2/13/23	2/21/24	2/25/25	3/13/26	-	-	-

¹SEK in Million

Estimates

Fiscal Period: December	2021 Q2	2021 Q3	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3
Net sales ¹	2.258	2.982	-	3.726	4.941	4.962	5.149	5.085	7.248	5.764	6.057	6.641	8.408	8.598	-	8.791	10.34
Change	-	32.06%	-	-	32.61%	0.43%	3.77%	-1.24%	42.54%	-20.47%	5.08%	9.64%	26.61%	2.26%	-	-	17.61%
EBITDA ¹	-10.42	-7.824	-	-10.82	-10.49	-12.68	-9.98	-12.82	-12.02	-15.82	-13.43	-13.92	-13.75	-22.84	-	-21.65	-16.94
Change	-	24.91%	-	-	3.05%	-20.85%	21.27%	-28.47%	6.27%	-31.64%	15.1%	-3.61%	1.16%	-66.06%	-	-	21.78%
EBIT ¹	-11.1	-8.583	-	-11.71	-11.38	-13.63	-10.78	-13.82	-12.73	-16.6	-14.26	-14.7	-14.59	-23.62	-	-22.36	-17.74
Change	-	22.7%	-	-	2.89%	-19.86%	20.91%	-28.2%	7.88%	-30.35%	14.07%	-3.06%	0.78%	-61.96%	-	-	20.64%
Charge d'intérêts	-	-	-	-	-	-	-	-	-	-	3.404	-0.349	-3.167	-	-	-	-
Earnings before Tax (EBT)	-	-	-	-	-	-	-	-	-	-20.54	-10.86	-15.05	-17.75	-	-	-	-
Change	-	-	-	-	-	-	-	-	-	-	47.13%	-38.57%	-17.96%	-	-	-	-
Net income	-	-	-9.736	-	-	-	-	-	-	-20.54	-10.86	-15.05	-17.75	-	-27.51	-	-
Change	-	-	-	-	-	-	-	-	-	-	47.13%	-38.57%	-17.96%	-	-	-	-
Announcement Date	8/19/21	11/11/21	5/12/22	8/18/22	11/10/22	2/13/23	5/10/23	8/18/23	11/10/23	2/21/24	5/31/24	8/21/24	11/12/24	2/25/25	5/13/25	8/19/25	11/7/25

¹SEK in Million

Estimates

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Net Debt	-	-13.6	-29.9	-9.68	-	-	-	-
Change	-	-	-119.85%	67.63%	-	-	-	-
Announcement Date	4/22/22	2/13/23	2/21/24	2/25/25	3/13/26	-	-	-

Estimates

Fiscal Period: December	2020	2021	2022	2023	2024	2025
CAPEX ¹	0.299	0.617	0.381	0.383	0.028	0.228
Change	-	106.35%	-38.25%	0.52%	-92.69%	714.29%
Free Cash Flow (FCF) ¹	-20.57	-24.91	-28.68	-33.21	-56.12	-28.87
Change	-	-21.13%	-15.14%	-15.79%	-68.96%	48.55%
Announcement Date	4/9/21	4/22/22	4/21/23	5/22/24	5/23/25	4/27/26

¹SEK in Million

Estimates

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027	2028
Profitability
EBITDA Margin (%)	-	-	-239.06%	-217.47%	-215.25%	-204.45%	-100.46%	-44.43%	-9.52%
EBIT Margin (%)	-	-	-259.47%	-232.05%	-226.14%	-213.57%	-100.46%	-49.42%	-12.67%
EBT Margin (%)	-	-	-241.33%	-239.13%	-205.77%	-215.18%	-100.61%	-49.42%	-12.67%
Net margin (%)	-	-	-241.33%	-239.13%	-205.77%	-215.18%	-100.61%	-49.42%	-12.67%
FCF margin (%)	-	-	-250.68%	-225.28%	-194.62%	-	-	-	-
FCF / Net Income (%)	-	-	103.88%	94.21%	94.58%	-	-	-	-
Profitability
ROA	-40.27%	-36.63%	-42.91%	-58.97%	-66.4%	-93.48%	-	-	-
ROE	-88.72%	-71.02%	-89.91%	-162.78%	-153.38%	-402.08%	-	-	-
Financial Health
Leverage (Debt/EBITDA)	-	-	-	-	-	-	-	-	-
Debt / Free cash flow	-	-	-	-	-	-	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	-	-	2.13%	1.65%	1.44%	-	-	-	-
CAPEX / EBITDA (%)	-	-	-0.89%	-0.76%	-0.67%	-	-	-	-
CAPEX / FCF (%)	-	-	-0.85%	-0.73%	-0.74%	-	-	-	-
Items per share
Cash flow per share ¹	75.62	95.81	27.5	28.47	5.122	5.457	-	-	-
Change	-	26.69%	-71.3%	3.54%	-82.01%	6.55%	-	-	-
Dividend per Share ¹	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-
Book Value Per Share ¹	85.54	103.4	36.86	35.93	16.69	1.607	-	-	-
Change	-	20.86%	-64.35%	-2.51%	-53.54%	-90.37%	-	-	-
EPS ¹	-112	-67	-63.05	-51.48	-34.34	-24.16	-	-	-
Change	-	40.18%	5.89%	18.36%	33.29%	29.65%	-	-	-
Nbr of stocks (in thousands)	548	685	685	1,198	2,195	4,142	-	-	-
Announcement Date	4/9/21	4/22/22	4/21/23	5/22/24	5/23/25	4/27/26	-	-	-